Investigations on differences in atorvastatin metabolites ratios as a diagnostic tool in detecting atorvastatin induced myotoxicity.

Trial Profile

Investigations on differences in atorvastatin metabolites ratios as a diagnostic tool in detecting atorvastatin induced myotoxicity.

Completed
Phase of Trial: Phase IV

Latest Information Update: 18 Aug 2009

At a glance

  • Drugs Atorvastatin (Primary)
  • Indications Lipid metabolism disorders
  • Focus Pharmacokinetics
  • Most Recent Events

    • 18 Aug 2009 Planned number of patients (53) added as reported by ClinicalTrials.gov.
    • 18 Aug 2009 Planned end date changed from 1 Mar 2009 to 1 Jun 2009 Last checked against ClinicalTrials.gov record.
    • 17 Jan 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top